Table 4 Annualised associations between multiply imputed DSM-IV ADHD and lost role performance among employed or self-employed respondents aged 18–44†
Individual levelNational level (in million of days)(n)
AbsenteeismQuantityQualityTotalAbsenteeismQuantityQualityTotal
Days(SE)Days(SE)Days(SE)Days(SE)Days(SE)Days(SE)Days(SE)Days(SE)
Belgium10.8(15.1)18.3(28.9)9.4(9.4)16.5(23.8)1.1(1.6)1.9(3.0)1.0(1.0)1.7(2.5)(347)
Colombia21.9*(9.4)14.3(9.9)13.0(9.6)29.4*(11.9)6.2*(2.7)4.1(2.8)3.7(2.7)8.3*(3.4)(790)
France−1.0(3.9)24.9(27.7)20.1(12.9)20.1(17.5)−1.0(4.0)25.5(28.3)20.6(13.2)20.6(17.9)(533)
Germany13.3(14.4)−3.6(4.9)3.9(4.6)13.6(14.6)10.6(11.5)−2.8(3.9)3.1(3.7)10.8(11.6)(432)
Italy7.7(9.5)25.6*(12.6)6.4(6.8)22.2(13.9)4.0(5.0)13.4*(6.6)3.3(3.6)11.6(7.2)(569)
Lebanon5.8(9.8)30.7(26.8)−4.1(4.0)19.4(13.3)0.1(0.1)0.4(0.4)−0.1(0.1)0.3(0.2)(305)
Mexico5.0(4.8)5.5(6.9)−0.9(1.0)6.1(6.7)2.4(2.3)2.6(3.3)−0.4(0.5)2.9(3.2)(749)
Netherlands−8.8(14.2)−37.3(16.8)−8.2(4.7)−28.4(15.8)−2.2(3.5)−9.3*(4.2)−2.0(1.2)−7.0(3.9)(389)
Spain−2.8(2.5)3.5(8.8)7.5(7.8)1.1(8.1)−0.4(0.3)0.5(1.2)1.0(1.0)0.1(1.1)(574)
USA10.0*(4.6)29.1*(9.0)20.6*(5.9)28.3*(8.4)37.0*(16.9)107.5*(33.4)76.1*(21.9)104.7*(31.2)(2387)
All countries8.4*(2.7)21.7*(5.6)13.6*(3.2)22.1*(4.8)54.8*(17.7)141.3*(36.7)88.6*(20.9)143.8*(31.5)(7075)
  • *Significant at the 0.05 level, two-sided test.

  • †Estimates are based on linear regression equations in which the role performance outcomes are regressed on a dummy predictor variable that distinguishes workers estimated to have ADHD from all other workers, controlling for age, gender, education and occupation.

  • ADHD, attention-defecit/hyperactivity disorder; SE, standard error.